A New Design Strategy in Nanomedicine Improves Antitumor Efficacy While Reducing Drug Dose

by Hospital de la Santa Creu i Sant Pau

the research team developed protein-based nanomedicines capable of self-assembling into multivalent nanoparticles and selectively targeting tumor cells that overexpress the CXCR4 receptor. This recept...

Read more

Nanoligent, a Spin-Off from IR Sant Pau and UAB, Raises €12 Million to Bring a CXCR4-Targeted Nanodrug to the Clinic

by Hospital de la Santa Creu i Sant Pau

Nanoligent, a spin-off from the Institut de Recerca Sant Pau (IR Sant Pau) and the Universitat Autnoma de Barcelona (UAB), has closed a €12 million funding round led by Inveready to advance the deve...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream